Evolent Health shareholders elect 10 directors, approve incentive plan amendment at June 4 meeting

Evolent Health, Inc.

All 10 director nominees elected with majority support; vote tallies range from 60.0M to 65.9M 'for' votes.
Advisory say-on-pay resolution approved 58.4M for vs 7.9M against (88% of votes cast).
Amendment to 2015 Omnibus Incentive Compensation Plan passed with 47.5M for, 18.7M against (71.8% of votes cast).
Ratification of Deloitte & Touche as auditor for FY2026 passed with 82.0M for, 0.1M against.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Evolent Health, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 as set forth below:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Evolent Health, Inc. shareholders approved Election of ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the 2027 annual meeting at the 2026-06-04 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

The Company’s stockholders elected ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the Company’s 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, as set forth below:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Evolent Health, Inc. shareholders approved Advisory approval of compensation of named executive officers for 2025 at the 2026-06-04 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

The Company’s stockholders approved the compensation of our named executive officers for 2025 on an advisory basis, as set forth below:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Evolent Health, Inc. shareholders approved Amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan at the 2026-06-04 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

The Company’s stockholders approved the amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan, as set forth below:

View on SEC.gov

339 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Evolent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628908-26-000037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.